Project Grant R43HL156378
Award Date
4/15/21
Completion Date
4/14/22
Dollars Obligated
$713K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Michigan, USA
Similar Awards
The National Heart, Lung, and Blood Institute (NHLBI) awarded Dynocardia, Inc. a $499,881 Project Grant under the Cardiovascular Diseases Research federal grant program (CFDA 93.837) to complete the verification and validation (V&V) of their production-grade ViTrack hospital device. ViTrack is a cuff-less, wrist-wearable device that uses proprietary optomechanical sensor and computer vision technology to provide accurate, continuous, non-invasive blood pressure monitoring for critically...
This National Science Foundation (NSF) Engineering program (CFDA 47.041) project grant award provides $347,386 to the University of Illinois to develop a novel wearable device for continuous, cuffless blood pressure (BP) monitoring. The goal is to create an accurate, inexpensive, and easy-to-use technology that can facilitate proactive management of hypertension and reduce hospitalizations related to this condition, which affects 45% of U.S. adults and is a leading risk factor for heart failure....
Dynocardia Inc. received a $256,000 National Science Foundation Project Grant to advance development of a novel continuous, cuffless blood pressure monitoring device. Funded through the NSF Engineering Directorate's SBIR program, the award will support Dynocardia's efforts to address motion artifacts and enable accurate, beat-to-beat blood pressure measurements in hospital intensive care and operating room settings. Accurate 24-hour blood pressure monitoring has potential to significantly...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $585,794 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Tele-Stethoscope Inc., a small disadvantaged business, for the development of a novel mobile phone technology to improve access to preeclampsia and hypertension detection. The project aims to demonstrate proof-of-concept that ordinary mobile phones can reproduce physicians' diagnosis of preeclampsia and detect hypertension through advanced...
The National Science Foundation awarded Vena Vitals Inc. a $1 million cooperative agreement under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a wireless, continuous, non-invasive blood pressure monitoring device. The device aims to address the unmet need for real-time blood pressure monitoring of patients undergoing surgery or in critical care by capturing rapid fluctuations with high temporal resolution. Current technologies are limited in accuracy, cost...
This $200,000 Project Grant awarded by the National Science Foundation (NSF) Division of Electrical, Communications and Cyber Systems under CFDA 47.041 (Engineering) aims to develop and implement a novel testing platform to evaluate the accuracy of wearable photoplethysmography-based blood pressure monitoring devices. The University of Maryland, College Park will construct a bench flow phantom that simulates physiologically relevant blood pressure, blood flow, anatomical, and optical...
This $999,998 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports the development of a novel long-acting conjugate of the vasodilative hormone, human brain natriuretic peptide (HBNP), to treat resistant hypertension. The grantee, Antlia Bioscience, Inc., is developing an innovative method to extend the lifespan of HBNP in the blood while maintaining its ability to lower blood pressure without...
The National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), awarded a $295,153 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to Safebeat RX Inc. The award supports the development of a novel, smartwatch-enabled, automated mobile heart rhythm analysis technology to allow low-risk atrial fibrillation patients to safely initiate antiarrhythmic medications at home. The technology aims to reproduce the in-hospital "drug...
This National Science Foundation (NSF) Cooperative Agreement award, under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, provides $999,553 to Dynocardia, Inc. to develop advanced computer vision and artificial intelligence algorithms for motion artifact correction in their Vitrack wearable blood pressure monitoring device. The project aims to improve the accuracy and reliability of Vitrack's continuous, non-invasive blood pressure measurements in clinical settings, where...
The National Institute of Child Health and Human Development (NICHD) awarded a Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Brigham & Women's Hospital Inc. in the amount of $237,827 to develop a wearable optical device for continuous non-invasive arterial blood pressure monitoring in neonates. The project aims to create a low-cost, wireless near-infrared spectroscopy (NIRS) device called CNAP-FLEXNIRS that can collect high-resolution...